GLP-1 Gray Market is Booming

Access is Broken

Originally posted on obesity.news on March 3th, 2026

Big shifts are happening in the GLP-1 world.

This week on On The Pen, we break down new federal action targeting pharmacy middlemen, potential FDA moves that could impact compounded semaglutide, and the rise of cash-pay weight loss clinics from companies like Walgreens and Amazon.

https://www.youtube.com/watch?v=iSeAwNR4kWU

If you’re navigating GLP-1 access, insurance denials, compounding changes, or wondering where this all heads next — this episode connects the dots so you can make informed decisions with your provider.

Are you currently getting your GLP-1 through insurance, cash-pay, or compounding, and how has that experience shaped your view of the healthcare system?

This article is reader-supported on Substack.

To receive new posts and support my work,

consider becoming a free or paid subscriber.

Subscribe